Howard Hughes Medical Institute’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-35
Closed -$16.3K 238
2025
Q4
$16.3K Sell
35
-1
-3% -$464 0.01% 135
2025
Q3
$15.3K Sell
36
-2
-5% -$775 0.01% 146
2025
Q2
$14.6K Buy
+38
New +$13.7K 0.01% 148
2016
Q4
Sell
-1,633
Closed -$124K 157
2016
Q3
$124K Buy
+1,633
New +$125K 0.03% 134
2015
Q3
Sell
-1,493
Closed -$135K 165
2015
Q2
$135K Sell
1,493
-4,921
-77% -$394K 0.03% 140
2015
Q1
$483K Buy
6,414
+4,600
+254% +$330K 0.07% 100
2014
Q4
$133K Buy
+1,814
New +$127K 0.04% 135
2014
Q2
Sell
-5,424
Closed -$285K 202
2014
Q1
$285K Sell
5,424
-185
-3% -$9.21K 0.04% 70
2013
Q4
$268K Buy
5,609
+1,601
+40% +$74K 0.04% 77
2013
Q3
$171K Sell
4,008
-1,944
-33% -$76K 0.03% 94
2013
Q2
$215K Buy
+5,952
New +$230K 0.07% 87

Other funds holding HCA

Howard Hughes Medical Institute's HCA Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of HCA Healthcare (HCA) in Q1 2026, closing a stake of 35 shares — an estimated $16.3K sold.

Howard Hughes Medical Institute first reported a position in HCA in Q2 2013 and held it in 11 quarters. The position peaked at $483K in Q1 2015. 1,415 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining HCA Healthcare position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 35 HCA Healthcare shares in Q1 2026, an estimated $16.3K.
  • Howard Hughes Medical Institute first reported a position in HCA Healthcare in Q2 2013 and held it in 11 quarters.
  • Howard Hughes Medical Institute's HCA Healthcare position peaked at $483K in Q1 2015.
  • 1,415 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.